AP
President Trump has signed into law a bill reauthorizing the user fees that help fund the Food and Drug Administration.
- It was one of the last bills the Senate passed before leaving for the August recess, and it could have easily turned into a battle, since the Trump administration wanted to restructure the medical product user fees to make the industry pay the full cost of product reviews.
- But congressional Republicans and Democrats ignored the request, and the administration didn't push the issue.
- Notable: It's one of the rare health care bills that's significant and yet passed easily, with bipartisan support and without a fight — and it could be one of the last for a while.